HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
HARP
Delisted
HARP was delisted on the 8th of March, 2024.
93 hedge funds and large institutions have $203M invested in Harpoon Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 33 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
33% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 33
43% less capital invested
Capital invested by funds: $357M → $203M (-$154M)
Holders
93
Holding in Top 10
3
Calls
$659K
Puts
$687K
Top Buyers
| 1 | +$4.66M | |
| 2 | +$3.21M | |
| 3 | +$3.17M | |
| 4 |
Two Sigma Advisers
New York
|
+$2.98M |
| 5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$1.7M |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$9.88M | |
| 3 | -$8.05M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$7.46M |
| 5 |
VA
VR Adviser
New York
|
-$7.1M |